Olaris, Inc.

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Olaris is working to fundamentally change how diseases are treated by leveraging our proprietary metabolomics and machine learning platform to identify Biomarker of Response (BoR) signatures. Olaris develops BoR in vitro diagnostics (IVDs) to empower patients, providers, and biopharma to pursue the most effective treatment.
Speaker
photo
CEO and Founder
Olaris, Inc.